TY  - GEN
AU  - Jonker,D J
AU  - Karapetis,C S
AU  - Harbison,C
AU  - O'Callaghan,C J
AU  - Tu,D
AU  - Simes,R J
AU  - Malone,D P
AU  - Langer,C
AU  - Tebbutt,N
AU  - Price,T J
AU  - Shapiro,J
AU  - Siu,L L
AU  - Wong,R P W
AU  - Bjarnason,G
AU  - Moore,M J
AU  - Zalcberg,J R
AU  - Khambata-Ford,S
TI  - Epiregulin gene expression as a biomarker of benefit from cetuximab in the treatment of advanced colorectal cancer
SN  - 1532-1827
PY  - 2014///0407
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Biomarkers, Tumor
KW  - genetics
KW  - Cetuximab
KW  - Clinical Trials, Phase III as Topic
KW  - Colorectal Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Epidermal Growth Factor
KW  - biosynthesis
KW  - Epiregulin
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Mutation
KW  - Neoplasm Staging
KW  - ras Proteins
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bjc.2013.753
ER  -